Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

[Limitations of insulin-dependent drugs in the treatment of type 2 diabetes mellitus].

Valerón PF, de Pablos-Velasco PL.

Med Clin (Barc). 2013 Sep;141 Suppl 2:20-5. doi: 10.1016/S0025-7753(13)70059-9. Review. Spanish.

PMID:
24444520
2.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A.

BMJ. 2012 Mar 12;344:e1369. doi: 10.1136/bmj.e1369.

PMID:
22411919
3.

Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Hermansen K, Mortensen LS.

Drug Saf. 2007;30(12):1127-42. Review.

PMID:
18035865
4.

Efficacy and safety of adding pioglitazone or sitagliptin to patients with type 2 diabetes insufficiently controlled with metformin and a sulfonylurea.

Liu SC, Chien KL, Wang CH, Chen WC, Leung CH.

Endocr Pract. 2013 Nov-Dec;19(6):980-8. doi: 10.4158/EP13148.OR.

PMID:
23807528
5.

What to add in with metformin in type 2 diabetes?

Petrie JR, Adler A, Vella S.

QJM. 2011 Mar;104(3):185-92. doi: 10.1093/qjmed/hcq237. Epub 2010 Dec 13. Review.

PMID:
21156663
6.

[Drug treatment of type 2 diabetes].

Tielmans A, Laloi-Michelin M, Coupaye M, Virally M, Meas T, Guillausseau PJ.

Presse Med. 2007 Feb;36(2 Pt 2):269-78. Epub 2006 Dec 11. Review. French.

PMID:
17258675
7.

Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis.

Zintzaras E, Miligkos M, Ziakas P, Balk EM, Mademtzoglou D, Doxani C, Mprotsis T, Gowri R, Xanthopoulou P, Mpoulimari I, Kokkali C, Dimoulou G, Rodopolou P, Stefanidis I, Kent DM, Hadjigeorgiou GM.

Clin Ther. 2014 Oct 1;36(10):1443-53.e9. doi: 10.1016/j.clinthera.2014.06.035. Epub 2014 Aug 8.

PMID:
25109773
8.

Diabetes update: new drugs to manage type 2 diabetes.

Erlich DR, Slawson DC, Shaughnessy A.

FP Essent. 2013 May;408:20-4. Review.

PMID:
23690375
9.

Complementing insulin therapy to achieve glycemic control.

Barnett AH.

Adv Ther. 2013 Jun;30(6):557-76. Review.

PMID:
23797471
10.

Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, Wang SJ, Yang CY, Lin CC, Chen TJ, Tarng DC, Li SY, Chen YT.

Ann Intern Med. 2015 Nov 3;163(9):663-72. doi: 10.7326/M15-0308. Epub 2015 Oct 13.

PMID:
26457538
11.

[Management of type 2 diabetes: new or previous agents, how to choose?].

Halimi S.

Presse Med. 2013 May;42(5):861-70. doi: 10.1016/j.lpm.2013.04.002. Epub 2013 May 2. Review. French.

PMID:
23643613
12.

Which oral agent to use when metformin is no longer effective?

Bannon M.

QJM. 2011 Mar;104(3):183-4. doi: 10.1093/qjmed/hcr015. No abstract available.

PMID:
21330402
13.

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.

Göke R, Gruenberger JB, Bader G, Dworak M.

Curr Med Res Opin. 2014 May;30(5):785-9. doi: 10.1185/03007995.2013.875464. Epub 2014 Jan 17.

PMID:
24328429
14.
15.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
16.

Treatment of Pediatric Type 2 Diabetes.

Smith JD, Mills E, Carlisle SE.

Ann Pharmacother. 2016 Sep;50(9):768-77. doi: 10.1177/1060028016655179. Epub 2016 Jun 15. Review.

PMID:
27307414
17.
18.

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials.

Monami M, Cremasco F, Lamanna C, Marchionni N, Mannucci E.

Diabetes Metab Res Rev. 2011 May;27(4):362-72. doi: 10.1002/dmrr.1184.

PMID:
21309062
19.

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.

Bolli G, Dotta F, Colin L, Minic B, Goodman M.

Diabetes Obes Metab. 2009 Jun;11(6):589-95. doi: 10.1111/j.1463-1326.2008.01023.x. Epub 2009 Apr 13.

PMID:
19515179
20.

Supplemental Content

Support Center